SCHEMBL12377215

SCHEMBL12377215

CCN1C(=O)c2c(C)ccc(C)c2C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.47
▸ CYP1B1 Q16678 5/20 0.44
▸ ALDH1A1 P00352 5/20 0.42
▸ LMNA P02545 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ GMNN O75496 1/20 0.42
▸ THPO P40225 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ MGLL Q99685 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ F2 P00734 1/20 0.42
▸ ELANE P08246 1/20 0.42
▸ CTSG P08311 1/20 0.42
▸ CTRC Q99895 1/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25706219 0.82 CISD1 (0.39) MAPK1ALDH1A1LMNAMAPTNPSR1
SCHEMBL12235606 0.80 TDP2 (0.48) MAPK1CYP1B1ALDH1A1LMNAMAPT
SCHEMBL12235632 0.80 CYP1B1 (0.58) MAPK1CYP1B1ALDH1A1LMNAMAPT
SCHEMBL21930007 0.79 MAPK1 (0.47) MAPK1CYP1B1ALDH1A1LMNAMAPT
SCHEMBL20576762 0.79 CYP1B1 (0.35) MAPK1CYP1B1ALDH1A1LMNAMAPT
SCHEMBL23665440 0.77 EP300 (0.40) MAPK1ALDH1A1LMNAMAPTMEN1
SCHEMBL20369502 0.76 HTR2A (0.39) MAPK1ALDH1A1LMNAELANEKMT2A
SCHEMBL20369482 0.76 HTR2A (0.39) MAPK1ALDH1A1LMNAELANEKMT2A
SCHEMBL12235769 0.75 F2 (0.46) MAPK1CYP1B1ALDH1A1LMNAMAPT
SCHEMBL12235615 0.74 LMNA (0.51) MAPK1CYP1B1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11932616-B2 Diels-Alder ring-opening process NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2024-03-19 — — US disclosed
EP-3788030-B1 DIELS- ALDER RING-OPENING PROCESS TNO (NL) 2023-06-07 — — EP disclosed
US-20210115005-A1 DIELS-ALDER RING-OPENING PROCESS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2021-04-22 — — US disclosed
EP-3788030-A1 DIELS- ALDER RING-OPENING PROCESS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2021-03-10 — — EP disclosed
US-20110204341-A1 ORGANIC ELECTRONIC DEVICES AND POLYMERS, INCLUDING PHOTOVOLTAIC CELLS AND DIKETONE-BASED POLYMERS PLEXTRONICS, INC. 2011-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115005-A1 DIELS-ALDER RING-OPENING PROCESS SQLE, GFER, OXER1 MAPK1 1636/4885CYP1B1 63/4885ALDH1A1 38/4885
US-11932616-B2 Diels-Alder ring-opening process SQLE, GFER, OXER1 MAPK1 1636/4885CYP1B1 63/4885ALDH1A1 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback